Study of Everolimus and Sorafenib in Patients With Advanced Thyroid Cancer Who Progressed on Sorafenib Alone

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT01263951

Recruitment Status : Active, not recruiting

First Posted : December 21, 2010

Last Update Posted : October 26, 2021

Sponsor:

Collaborators:

Bayer

Novartis Pharmaceuticals

Information provided by (Responsible Party):

Thomas Jefferson University

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Active, not recruiting
Actual Primary Completion Date :	February 1, 2021
Estimated Study Completion Date :	May 2022

To Top